Historical Valuation
CVS Health Corp (CVS) is now in the Fair zone, suggesting that its current forward PE ratio of 11.66 is considered Fairly compared with the five-year average of 10.19. The fair price of CVS Health Corp (CVS) is between 80.47 to 96.05 according to relative valuation methord.
Relative Value
Fair Zone
80.47-96.05
Current Price：80.60
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
CVS Health Corp (CVS) has a current Price-to-Book (P/B) ratio of 1.40. Compared to its 3-year average P/B ratio of 1.17 , the current P/B ratio is approximately 18.99% higher. Relative to its 5-year average P/B ratio of 1.36, the current P/B ratio is about 2.30% higher. CVS Health Corp (CVS) has a Forward Free Cash Flow (FCF) yield of approximately 6.19%. Compared to its 3-year average FCF yield of 10.07%, the current FCF yield is approximately -38.58% lower. Relative to its 5-year average FCF yield of 11.09% , the current FCF yield is about -44.20% lower.
P/B
Median3y
1.17
Median5y
1.36
FCF Yield
Median3y
10.07
Median5y
11.09
Competitors Valuation Multiple
AI Analysis for CVS
The average P/S ratio for CVS competitors is 0.77, providing a benchmark for relative valuation. CVS Health Corp Corp (CVS.N) exhibits a P/S ratio of 0.25, which is -67.36% above the industry average. Given its robust revenue growth of 7.80%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for CVS
1Y
3Y
5Y
Market capitalization of CVS increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of CVS in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is CVS currently overvalued or undervalued?
CVS Health Corp (CVS) is now in the Fair zone, suggesting that its current forward PE ratio of 11.66 is considered Fairly compared with the five-year average of 10.19. The fair price of CVS Health Corp (CVS) is between 80.47 to 96.05 according to relative valuation methord.
What is CVS Health Corp (CVS) fair value?
CVS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of CVS Health Corp (CVS) is between 80.47 to 96.05 according to relative valuation methord.
How does CVS's valuation metrics compare to the industry average?
The average P/S ratio for CVS's competitors is 0.77, providing a benchmark for relative valuation. CVS Health Corp Corp (CVS) exhibits a P/S ratio of 0.25, which is -67.36% above the industry average. Given its robust revenue growth of 7.80%, this premium appears unsustainable.
What is the current P/B ratio for CVS Health Corp (CVS) as of Jan 09 2026?
As of Jan 09 2026, CVS Health Corp (CVS) has a P/B ratio of 1.40. This indicates that the market values CVS at 1.40 times its book value.
What is the current FCF Yield for CVS Health Corp (CVS) as of Jan 09 2026?
As of Jan 09 2026, CVS Health Corp (CVS) has a FCF Yield of 6.19%. This means that for every dollar of CVS Health Corp’s market capitalization, the company generates 6.19 cents in free cash flow.
What is the current Forward P/E ratio for CVS Health Corp (CVS) as of Jan 09 2026?
As of Jan 09 2026, CVS Health Corp (CVS) has a Forward P/E ratio of 11.66. This means the market is willing to pay $11.66 for every dollar of CVS Health Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for CVS Health Corp (CVS) as of Jan 09 2026?
As of Jan 09 2026, CVS Health Corp (CVS) has a Forward P/S ratio of 0.25. This means the market is valuing CVS at $0.25 for every dollar of expected revenue over the next 12 months.